Phase II/III randomized trial of exclusive chemoradiotherapy with or without dose escalation in locally advanced esophageal carcinoma: The CONCORDE study (PRODIGE 26).

Affiliation auteurs!!!! Error affiliation !!!!
TitrePhase II/III randomized trial of exclusive chemoradiotherapy with or without dose escalation in locally advanced esophageal carcinoma: The CONCORDE study (PRODIGE 26).
Type de publicationJournal Article
Year of Publication2016
AuteursCrehange G, Bonnetain F, Peiffert D, Le Prise E, Etienne P-L, Rio E, Pereira R, Noel G, Benezery K, Seitz JFrancois
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedFEB 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2016.34.4_suppl.tps190